PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer


Basic Trial Information

Protocol Phase:Phase II
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorNCI
Primary IDNCI-2012-02086
Other IDNCT01010126
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: